BORRONI, BARBARA
 Distribuzione geografica
Continente #
NA - Nord America 26.125
AS - Asia 13.179
EU - Europa 10.802
SA - Sud America 3.547
AF - Africa 273
OC - Oceania 32
Continente sconosciuto - Info sul continente non disponibili 27
Totale 53.985
Nazione #
US - Stati Uniti d'America 25.758
SG - Singapore 4.454
CN - Cina 4.263
BR - Brasile 3.013
UA - Ucraina 2.440
DE - Germania 2.294
HK - Hong Kong 1.887
IT - Italia 1.351
VN - Vietnam 948
PL - Polonia 862
GB - Regno Unito 858
RU - Federazione Russa 816
FI - Finlandia 709
TR - Turchia 502
IE - Irlanda 438
FR - Francia 408
IN - India 297
AR - Argentina 233
BD - Bangladesh 188
CA - Canada 159
MX - Messico 132
SE - Svezia 128
BE - Belgio 98
NL - Olanda 98
ID - Indonesia 96
IQ - Iraq 95
ZA - Sudafrica 95
EC - Ecuador 86
AT - Austria 83
JP - Giappone 63
CZ - Repubblica Ceca 61
CO - Colombia 55
ES - Italia 54
PY - Paraguay 51
SA - Arabia Saudita 49
PK - Pakistan 48
MA - Marocco 47
UZ - Uzbekistan 46
VE - Venezuela 36
CL - Cile 33
AU - Australia 28
KE - Kenya 26
EU - Europa 22
IL - Israele 22
KR - Corea 22
EG - Egitto 20
IR - Iran 20
TN - Tunisia 20
JO - Giordania 19
LT - Lituania 19
AE - Emirati Arabi Uniti 18
UY - Uruguay 18
DO - Repubblica Dominicana 17
MU - Mauritius 17
NP - Nepal 16
PE - Perù 16
AZ - Azerbaigian 15
KZ - Kazakistan 15
DZ - Algeria 14
BG - Bulgaria 12
JM - Giamaica 12
RO - Romania 12
TW - Taiwan 11
BH - Bahrain 10
HN - Honduras 10
LB - Libano 9
TH - Thailandia 9
CR - Costa Rica 8
MY - Malesia 8
PH - Filippine 8
BY - Bielorussia 7
CI - Costa d'Avorio 7
EE - Estonia 7
LV - Lettonia 7
PS - Palestinian Territory 7
DK - Danimarca 6
SN - Senegal 6
AM - Armenia 5
BB - Barbados 5
BO - Bolivia 5
CH - Svizzera 5
ET - Etiopia 5
KW - Kuwait 5
NO - Norvegia 5
OM - Oman 5
TT - Trinidad e Tobago 5
XK - ???statistics.table.value.countryCode.XK??? 5
GT - Guatemala 4
KG - Kirghizistan 4
PA - Panama 4
RS - Serbia 4
AL - Albania 3
GD - Grenada 3
HR - Croazia 3
HU - Ungheria 3
LK - Sri Lanka 3
NI - Nicaragua 3
NZ - Nuova Zelanda 3
PT - Portogallo 3
TG - Togo 3
Totale 53.945
Città #
Fairfield 3.708
Woodbridge 2.816
Ashburn 2.083
Singapore 2.065
Houston 1.897
Hong Kong 1.879
Jacksonville 1.771
Seattle 1.464
Cambridge 1.347
Ann Arbor 1.322
Wilmington 1.241
Beijing 934
Warsaw 853
Princeton 786
Nanjing 644
Chandler 626
New York 572
Dublin 436
Istanbul 423
Los Angeles 406
Ho Chi Minh City 349
Helsinki 343
Dallas 340
Dearborn 325
The Dalles 309
Munich 281
São Paulo 263
Nanchang 247
Moscow 239
Des Moines 231
Buffalo 230
Brescia 227
Redondo Beach 198
Milan 195
Hanoi 190
Shenyang 178
Changsha 172
San Diego 171
Shanghai 138
Hebei 135
Chicago 130
Jinan 130
San Francisco 122
Tianjin 112
London 107
Turku 106
Nuremberg 103
Rio de Janeiro 99
Jiaxing 98
Brussels 91
Lancaster 91
Kunming 84
Belo Horizonte 80
Boardman 73
Brooklyn 73
Santa Clara 72
Guangzhou 59
Hangzhou 59
Zhengzhou 53
Tokyo 52
Toronto 52
Ningbo 50
Phoenix 50
Denver 48
Norwalk 48
Rome 47
Verona 47
San Mateo 45
Montreal 44
Johannesburg 43
Nürnberg 42
Tashkent 42
Curitiba 40
Porto Alegre 40
Haiphong 39
Stockholm 38
Brasília 37
Mexico City 37
Taizhou 37
Atlanta 36
Dhaka 36
Romola 36
Vienna 35
Salvador 34
Augusta 33
Frankfurt am Main 33
Olomouc 33
Quito 33
Baghdad 32
Charlotte 31
Da Nang 31
Lanzhou 31
Biên Hòa 30
Boston 30
Chennai 30
Dong Ket 30
Goiânia 29
Guarulhos 28
Mumbai 28
Poplar 28
Totale 35.321
Nome #
[(11)C]-MP4A PET cholinergic measurements in amnestic mild cognitive impairment, probable Alzheimer's disease, and dementia with Lewy bodies: a Bayesian method and voxel-based analysis 398
White matter changes in corticobasal degeneration syndrome and correlation with limb apraxia. 254
Granulin mutation drives brain damage and reorganization from preclinical to symptomatic FTLD. 247
The Frontal Behavioural Inventory (Italian version) differentiates frontotemporal lobar degeneration variants from Alzheimer's disease. 241
"Alien face" in corticobasal degeneration syndrome: Extending clinical features [2] 235
Mutation within TARDBP leads to Frontotemporal Dementia without motor neuron disease. 230
Evidence of white matter changes on diffusion tensor imaging in frontotemporal dementia. 227
Intronic CYP46 polymorphism along with ApoE genotype in sporadic Alzheimer Disease: from risk factors to disease modulators 216
Discrimination of atypical parkinsonisms with transcranial magnetic stimulation 215
COVID-19 impact on consecutive neurological patients admitted to the emergency department 209
Clinical and neuroanatomical signatures of tissue pathology in frontotemporal lobar degeneration. 208
CSF Alzheimer's disease-like pattern in Corticobasal Syndrome: evidence for a distinct disorder. 206
Altered brain metabolic connectivity at multiscale level in early Parkinson's disease 206
Mild Cognitive Impairment and Progression to Dementia in Progressive Supranuclear Palsy 202
Source-Based Morphometry Multivariate Approach to Analyze [123I]FP-CIT SPECT Imaging 199
Is aceruloplasminemia treatable? Combining iron chelation and fresh-frozen plasma treatment 198
Mendelian forms of disease and age at onset affect survival in frontotemporal dementia 195
QT dispersion and heart rate variability abnormalities in Alzheimer's disease and in mild cognitive impairment. 194
Synapsin III is a key component of α-synuclein fibrils in Lewy bodies of PD brains 192
Diagnosis of Mild Cognitive Impairment Due to Alzheimer's Disease with Transcranial Magnetic Stimulation 189
Action and object naming in frontotemporal dementia, progressive supranuclear palsy, and corticobasal degeneration 188
A complicated case of intracranial hypotension: Diagnostic and management strategies 188
Cortico-spinal tDCS in ALS: A randomized, double-blind, sham-controlled trial 188
Increased prevalence of silent myocardial ischaemia and severe ventricular arrhythmias in untreated patients with Alzheimer's disease and mild cognitive impairment without overt coronary artery disease 186
Extrapyramidal symptoms in Frontotemporal Dementia: prevalence and clinical correlations 184
Abnormalities in the pattern of platelet amyloid precursor protein forms in patients with mild cognitive impairment and Alzheimer disease. 181
A case report: doctor, my daughter has Alzheimer's disease. 180
Single-subject SPM FDG-PET patterns predict risk of dementia progression in Parkinson disease 180
Structural and functional imaging study in dementia with Lewy bodies and Parkinson's disease dementia. 179
Do Beliefs about the Pathogenetic Role of Amyloid Affect the Interpretation of Amyloid PET in the Clinic. 179
Clinical characteristics and outcomes of inpatients with neurologic disease and COVID-19 in Brescia, Lombardy, Italy 172
Education plays a different role in Frontotemporal Dementia and Alzheimer's disease 171
TARDBP mutations in frontotemporal lobar degeneration: frequency, clinical features, and disease course. 171
A complicated case of intracranial hypotension: diagnostic and management strategies. 170
Platelet amyloid precursor protein abnormalities in mild cognitive impairment predict conversion to dementia of Alzheimer type: a 2-year follow-up study. 169
Results from a pilot study on amiodarone administration in monogenic frontotemporal dementia with granulin mutation 168
EEG and granular osmiophilic elements in early-onset Alzheimer's disease. 166
Is early-onset clinicallydifferent from late-onset frontotemporal dementia? 165
Diffusion tensor imaging and voxel based morphometry study in early progressive supranuclear palsy 165
Transcranial magnetic stimulation distinguishes Alzheimer disease from frontotemporal dementia 165
Autoimmunity and frontotemporal dementia 165
Extrastriatal dopaminergic and serotonergic pathways in Parkinson’s disease and in dementia with Lewy bodies: a 123I-FP-CIT SPECT study 165
A functional polymorphism within plasminogen activator urokinase (PLAU) is associated with Alzheimer's disease 162
Functional correlates of Apolipoprotein E genotype in Frontotemporal Lobar Degeneration 162
Functional and structural changes in Alzheimer’s disease and Mild Cognitive Impairment. Possible predictive role of QT Dispersion and Heart Rate Variability analisys 162
The impact of transcranial magnetic stimulation on diagnostic confidence in patients with Alzheimer disease 161
Stimulation over the cerebellum with a regular figure-of-eight coil induces reduced motor cortex inhibition in patients with progressive supranuclear palsy 161
A comparative clinical, pathological, biochemical and genetic study of fused in sarcoma proteinopathies. 160
Early stage of behavioral variant frontotemporal dementia: clinical and neuroimaging correlates. 160
The Italian dementia with Lewy bodies study group (DLB-SINdem): toward a standardization of clinical procedures and multicenter cohort studies design 159
Cognitive and behavioral assessment in the early stages of neurodegenerative extrapyramidalsyndromes 158
Subcortical and deep cortical atrophy in Frontotemporal Lobar Degeneration. 155
Metodo di generazione di un indice diagnostico per malattia di alzheimer, apparato elettronico di implementazione del metodo e sistema 155
Choreo-athetosis in LRRK2 R1441C mutation: expanding the clinical phenotype. 154
Understanding phenotype variability in frontotemporal lobar degeneration due to granulin mutation. 154
Prefrontal cortex rTMS enhances action naming in Progressive Non-Fluent Aphasia 152
Diagnosing Progressive Supranuclear Palsy: Role of Biological and Neuroimaging Markers 152
Sensitivity and specificity of transcranial magnetic stimulation for differential diagnosis of Alzheimer’s disease and frontotemporal dementia 152
Vascular risk factors and cognition in Parkinson's disease 152
Clinical and biomarker changes in presymptomatic genetic frontotemporal dementia 152
Anti-GluA3 antibodies in frontotemporal dementia: effects on glutamatergic neurotransmission and synaptic failure 152
Enhancing theory of mind in behavioural variant frontotemporal dementia with transcranial direct current stimulation 152
Genetic bases of Progressive Supranuclear Palsy: the MAPT tau disease. 151
Treatment of primary progressive aphasias by transcranial direct current stimulation combined with language training 151
Amyloid precursor protein in platelets: a peripheral marker for the diagnosis of sporadic AD 150
A PCR-based protocol to accurately size C9orf72 intermediate-length alleles. 150
Acombination of CSF tau ratio and midsaggital midbraintopons atrophy for the earlydiagnosis of progressive supranuclear palsy 149
Two Sequential Tc-99m ECD SPECT Studies in a Case of Sporadic Creutzfeldt–Jakob Disease Confirmed at Autopsy 149
Cerebellar transcranial direct current stimulation in patients with ataxia: A double-blind, randomized, sham-controlled study. 149
Voluptuary Habits and Risk of Frontotemporal Dementia: A Case Control Retrospective Study 149
Atypical presentation of a novel Presenilin 1 R377W mutation: sporadic, late-onset Alzheimer disease with epilepsy and frontotemporal atrophy. 147
Iron in Frontotemporal Lobar Degeneration: A New Subcortical Pathological Pathway? 147
Cardiac arrhythmias and silent myocardial ischaemia in Mild Cognitive Impairment and Alzheimer Disease 146
The Speech and Language FOXP2 GeneModulates the Phenotype of Frontotemporal Lobar Degeneration 146
The brain-derived neurotrophic factor (BDNF) Val66Met polymorphism is not significantly correlated to Transient Global Amnesia: preliminary results of an on-going study in Brescia Province, Italy. 146
Early maturation and distinct tau pathology in induced pluripotent stem cell-derived neurons from patients with MAPT mutations. 146
Survival in frontotemporal lobar degeneration and related disorders: latent class predictors and brain functional correlates 145
Docosahexaenoic acid is a beneficial replacement treatment for spinocerebellar ataxia 38. 145
Serum leptin levels are higher in females affected by frontotemporal lobar degeneration than Alzheimer's disease 144
Advances on biological markers in early diagnosis of Alzheimer disease 144
APOE genotype and cholesterol levels in lewy body dementia and Alzheimer disease: investigating genotype-phenotype effect on disease risk 143
Left parietal cortex transcranial direct current stimulation enhances gesture processing in corticobasal syndrome. 143
Serum C-Peptide, Visfatin, Resistin, and Ghrelin are Altered in Sporadic and GRN-Associated Frontotemporal Lobar Degeneration 143
Association between tau H2 haplotype and age at onset in frontotemporal dementia 142
Beyond cognitive reserve: behavioural reserve hypothesis in Frontotemporal Dementia. 141
Antinuclear antibodies in Frontotemporal Dementia: the tip's of autoimmunity iceberg? 141
Behavioral dimensions and acetylcholinesterase inhibitor-related effect in Alzheimer disease over time: a latent trajectory modeling. 140
Anodal transcranial direct current stimulation of parietal cortex enhances action naming in Corticobasal Syndrome. 140
Understanding Emotions in Frontotemporal Dementia: The Explicit and Implicit Emotional Cue Mismatch. 140
Familial aggregation in Progressive Supranuclear Palsy and Corticobasal Syndrome. 139
Natural history and predictors of survival in progressive supranuclear palsy. 139
Endothelial nitric oxide synthase polymorphisms as risk factors for migraine: a response. 138
Response to comments on natural history and predictors of survival in progressive supranuclear palsy 138
ADAM10 gene expression in the blood cells of Alzheimer's disease patients and mild cognitive impairment subjects. 137
Cardiovascular structural and functional changes in Mild Cognitive Impairment and Alzheimer Disease.Potential predictive role of QT Dispersion and Heart Rate Variability Analysis 136
Presymptomatic cognitive and neuroanatomical changes in genetic frontotemporal dementia in the Genetic Frontotemporal dementia Initiative (GENFI) study: a cross-sectional analysis. 136
Pattern ofbehavioral disturbances in corticobasal degeneration syndrome and progressivesupranuclear palsy 136
Multimodal Brain Analysis of Functional Neurological Disorders: A Functional Stroke Mimic Case Series. 136
Specific neuroautonomic changes by Heart Rate Varibility Analysis in Parkinson’s disease, Multiple System Atrophy, and Lewy Bodies dementia 135
Clinical, biological, and imaging features of monogenic Alzheimer's Disease. 135
Totale 16.865
Categoria #
all - tutte 272.454
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 272.454


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20214.001 0 0 0 0 0 680 245 720 784 617 698 257
2021/20223.171 213 539 69 148 29 162 228 236 190 416 280 661
2022/20232.442 448 115 63 152 155 675 24 171 273 71 171 124
2023/20243.243 169 72 289 209 107 499 111 117 950 65 58 597
2024/20259.056 79 50 88 1.262 1.015 729 824 255 934 775 1.835 1.210
2025/202610.951 1.720 2.801 1.735 3.089 1.415 191 0 0 0 0 0 0
Totale 54.763